Clinical Trial Update: Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial at Fuzhou General Hospital is evaluating mesenchymal stem cell transplantation for chronic allograft nephropathy in kidney t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allograft Nephropathy

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Kidney Transplant, Chronic Allograft Nephropathy | Phase 1, Phase 2 | Status: UNKNOWN